Unraveling the immune mechanisms and therapeutic targets in lung adenosquamous transformation

Adenocarcinoma-to-squamous cell carcinoma transformation (AST) induces drug resistance in patients with lung adenocarcinoma (LUAD), often resulting in unfavorable clinical outcomes. In recent years, it has been found that alterations in the tumor immune microenvironment (TIME) during adenosquamous c...

Full description

Saved in:
Bibliographic Details
Main Authors: Haiyan Xu, Ying Yang, PingLi Wang, Shengnan Lin, Xiaochun Zhang, Huiwen Ni, Zhiyong Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1542526/full
Tags: Add Tag
No Tags, Be the first to tag this record!